In Patient Information Center iX (PICiX) Versions C.02 and C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX550, MX750, MX850, and IntelliVue X3 Versions N and prior, the software does not check or incorrectly checks the revocation status of a certificate, which may cause it to use a compromised certificate.
This vulnerability carries a MEDIUM severity rating with a CVSS v3.1 score of 6.4, indicating it requires adjacent network access with relatively low complexity without requiring user interaction . The vulnerability impacts confidentiality (data exposure), integrity (unauthorized modifications), and limited availability for affected systems. Impacting 24 products from philips, from philips, from philips and 21 others, organizations running these solutions should prioritize assessment and patching.
Reported in 2020, this vulnerability emerged during an era marked by increased sophistication in supply chain attacks, cloud infrastructure vulnerabilities, and software-as-a-service (SaaS) security challenges. Security practices during this period emphasized zero-trust architectures, container security, and API protection.
2020-09-11T13:15:11.377
2026-02-23T18:20:59.040
Modified
CVSSv3.1: 6.4 (MEDIUM)
AV:A/AC:L/Au:S/C:P/I:P/A:P
5.1
6.4
SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For philips's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.